Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100635 in the mouse
- 27 December 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 271 (2) , 505-514
- https://doi.org/10.1016/0014-2999(94)90812-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agentsTrends in Pharmacological Sciences, 1993
- WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptorsEuropean Journal of Pharmacology, 1993
- [3H]RP 62203, a ligand of choice to label in vivo brain 5-HT2 receptorsEuropean Journal of Pharmacology, 1992
- S 14506: A novel, potent, high‐efficacy 5‐HT1A agonist and potential anxiolytic agentDrug Development Research, 1992
- A Method for the In Vivo Investigation of the Serotonergic 5‐HT2 Receptors in the Human Cerebral Cortex Using Positron Emission Tomography and 18F‐Labeled SetoperoneJournal of Neurochemistry, 1990
- [18F]Setoperone: A new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivoEuropean Journal of Pharmacology, 1988
- In vivo [3H]ketanserin binding: effect of modifying synaptic serotonin levelsNeurochemistry International, 1988
- The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and ratsPsychopharmacology, 1986
- Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PATNature, 1983
- REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐IJournal of Neurochemistry, 1966